Intelligent Bio Solutions (INBS) Current Deferred Tax Assets (2020 - 2023)

Intelligent Bio Solutions (INBS) recorded quarterly Current Deferred Tax Assets of $34100.0 in Q2 2023, down 88.63% quarter-over-quarter from $300000.0 in Q3 2022.

Intelligent Bio Solutions (INBS) Current Deferred Tax Assets (2020 - 2023) Analysis & Trends

Intelligent Bio Solutions' Current Deferred Tax Assets history runs 3 years deep, the most recent figure standing at $34100.0 for Q2 2023.

  • In Q2 2023, Current Deferred Tax Assets changed N/A year-over-year to $34100.0; the TTM figure through Jun 2023 stood at $34100.0 (changed N/A YoY), while the FY2023 annual figure was $34100.0, changed N/A from the prior year.
  • Current Deferred Tax Assets was $34100.0 for Q2 2023 at Intelligent Bio Solutions, down from $300000.0 in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $1.9 million in Q2 2020 to a low of $34100.0 in Q2 2023.
  • Historically, Current Deferred Tax Assets has averaged $732571.0 across 3 years, with a median of $300000.0 in 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Intelligent Bio Solutions 12.67 Mn 11.47 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 34,100.00
Jun 30, 2023 34,100.00
Sep 30, 2022 300,000.00
Sep 30, 2022 300,000.00
Jun 30, 2020 1.86 Mn
Jun 30, 2020 1.86 Mn